Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Accumulated Expenses (2017 - 2026)

Nutex Health (NUTX) has disclosed Accumulated Expenses for 10 consecutive years, with $32.5 million as the latest value for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 31.9% year-over-year to $32.5 million; the TTM value through Mar 2026 reached $32.5 million, up 31.9%, while the annual FY2025 figure was $26.8 million, 5.24% up from the prior year.
  • Accumulated Expenses hit $32.5 million in Q1 2026 for Nutex Health, up from $26.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $32.5 million in Q1 2026 and bottomed at $157233.0 in Q1 2022.
  • Average Accumulated Expenses over 5 years is $22.2 million, with a median of $26.1 million recorded in 2024.
  • Year-over-year, Accumulated Expenses decreased 22.26% in 2022 and then surged 96.37% in 2024.
  • Nutex Health's Accumulated Expenses stood at $157233.0 in 2022, then skyrocketed by 8139.55% to $13.0 million in 2023, then soared by 96.37% to $25.4 million in 2024, then increased by 5.24% to $26.8 million in 2025, then grew by 21.39% to $32.5 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $32.5 million, $26.8 million, and $27.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.